The role of receptor for advanced glycation end products (RAGE) in the proliferation of hepatocellular carcinoma

Al Madhagi Yaser, Yan Huang, Rong Rong Zhou, Guan Sheng Hu, Mei Fang Xiao, Zhe Bing Huang, Chao Jun Duan, Wei Tian, Dao Lin Tang, Xue Gong Fan

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The receptor for advanced glycation end products (RAGE) is oncogenic and overexpressed in human cancers, but its role in hepatocellular carcinoma remains unclear. Here we demonstrated that RAGE is overexpressed in primary hepatocellular carcinoma (PHC) compared to adjacent para-neoplastic liver samples. Serum endogenous secretory RAGE levels were also increased in PHC patients (p < 0.01). Moreover, we demonstrated that RAGE regulates cellular proliferation in Hepatocellular carcinoma (HCC). Knockdown of RAGE by specific siRNA inhibited cellular growth in the hepatocellular carcinoma cell line, Huh7, whereas the RAGE ligand, high mobility group box 1 protein (HMGB1) increased cellular proliferation. In addition, knockdown of RAGE by siRNA arrested cells in the G1 phase and inhibited DNA synthesis (p < 0.01), while HMGB1 protein decreased the number of cells in the G1 phase and increased the number in the S phase (p < 0.05). Furthermore, quantitative real time RT-PCR (qRT-PCR) and Western Blot results demonstrated that RAGE and HMGB1 positively regulate NF-κB p65 expression in Huh7 cells. These studies suggest that RAGE and RAGE ligands are important targets for therapeutic intervention in hepatocellular carcinoma.

Original languageEnglish (US)
Pages (from-to)5982-5997
Number of pages16
JournalInternational journal of molecular sciences
Volume13
Issue number5
DOIs
StatePublished - May 1 2012
Externally publishedYes

Fingerprint

Hepatocellular Carcinoma
cancer
Proteins
products
HMGB1 Protein
Ligands
proteins
boxes
Liver
G1 Phase
DNA
Cells
Small Interfering RNA
cells
Cell Proliferation
Advanced Glycosylation End Product-Specific Receptor
ligands
S Phase
cultured cells
liver

Keywords

  • HMGB1
  • NF-κb
  • Proliferation
  • RAGE
  • SiRNA

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

The role of receptor for advanced glycation end products (RAGE) in the proliferation of hepatocellular carcinoma. / Yaser, Al Madhagi; Huang, Yan; Zhou, Rong Rong; Hu, Guan Sheng; Xiao, Mei Fang; Huang, Zhe Bing; Duan, Chao Jun; Tian, Wei; Tang, Dao Lin; Fan, Xue Gong.

In: International journal of molecular sciences, Vol. 13, No. 5, 01.05.2012, p. 5982-5997.

Research output: Contribution to journalArticle

Yaser, Al Madhagi ; Huang, Yan ; Zhou, Rong Rong ; Hu, Guan Sheng ; Xiao, Mei Fang ; Huang, Zhe Bing ; Duan, Chao Jun ; Tian, Wei ; Tang, Dao Lin ; Fan, Xue Gong. / The role of receptor for advanced glycation end products (RAGE) in the proliferation of hepatocellular carcinoma. In: International journal of molecular sciences. 2012 ; Vol. 13, No. 5. pp. 5982-5997.
@article{1054a43148d542c285a2386180b8dddf,
title = "The role of receptor for advanced glycation end products (RAGE) in the proliferation of hepatocellular carcinoma",
abstract = "The receptor for advanced glycation end products (RAGE) is oncogenic and overexpressed in human cancers, but its role in hepatocellular carcinoma remains unclear. Here we demonstrated that RAGE is overexpressed in primary hepatocellular carcinoma (PHC) compared to adjacent para-neoplastic liver samples. Serum endogenous secretory RAGE levels were also increased in PHC patients (p < 0.01). Moreover, we demonstrated that RAGE regulates cellular proliferation in Hepatocellular carcinoma (HCC). Knockdown of RAGE by specific siRNA inhibited cellular growth in the hepatocellular carcinoma cell line, Huh7, whereas the RAGE ligand, high mobility group box 1 protein (HMGB1) increased cellular proliferation. In addition, knockdown of RAGE by siRNA arrested cells in the G1 phase and inhibited DNA synthesis (p < 0.01), while HMGB1 protein decreased the number of cells in the G1 phase and increased the number in the S phase (p < 0.05). Furthermore, quantitative real time RT-PCR (qRT-PCR) and Western Blot results demonstrated that RAGE and HMGB1 positively regulate NF-κB p65 expression in Huh7 cells. These studies suggest that RAGE and RAGE ligands are important targets for therapeutic intervention in hepatocellular carcinoma.",
keywords = "HMGB1, NF-κb, Proliferation, RAGE, SiRNA",
author = "Yaser, {Al Madhagi} and Yan Huang and Zhou, {Rong Rong} and Hu, {Guan Sheng} and Xiao, {Mei Fang} and Huang, {Zhe Bing} and Duan, {Chao Jun} and Wei Tian and Tang, {Dao Lin} and Fan, {Xue Gong}",
year = "2012",
month = "5",
day = "1",
doi = "10.3390/ijms13055982",
language = "English (US)",
volume = "13",
pages = "5982--5997",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "5",

}

TY - JOUR

T1 - The role of receptor for advanced glycation end products (RAGE) in the proliferation of hepatocellular carcinoma

AU - Yaser, Al Madhagi

AU - Huang, Yan

AU - Zhou, Rong Rong

AU - Hu, Guan Sheng

AU - Xiao, Mei Fang

AU - Huang, Zhe Bing

AU - Duan, Chao Jun

AU - Tian, Wei

AU - Tang, Dao Lin

AU - Fan, Xue Gong

PY - 2012/5/1

Y1 - 2012/5/1

N2 - The receptor for advanced glycation end products (RAGE) is oncogenic and overexpressed in human cancers, but its role in hepatocellular carcinoma remains unclear. Here we demonstrated that RAGE is overexpressed in primary hepatocellular carcinoma (PHC) compared to adjacent para-neoplastic liver samples. Serum endogenous secretory RAGE levels were also increased in PHC patients (p < 0.01). Moreover, we demonstrated that RAGE regulates cellular proliferation in Hepatocellular carcinoma (HCC). Knockdown of RAGE by specific siRNA inhibited cellular growth in the hepatocellular carcinoma cell line, Huh7, whereas the RAGE ligand, high mobility group box 1 protein (HMGB1) increased cellular proliferation. In addition, knockdown of RAGE by siRNA arrested cells in the G1 phase and inhibited DNA synthesis (p < 0.01), while HMGB1 protein decreased the number of cells in the G1 phase and increased the number in the S phase (p < 0.05). Furthermore, quantitative real time RT-PCR (qRT-PCR) and Western Blot results demonstrated that RAGE and HMGB1 positively regulate NF-κB p65 expression in Huh7 cells. These studies suggest that RAGE and RAGE ligands are important targets for therapeutic intervention in hepatocellular carcinoma.

AB - The receptor for advanced glycation end products (RAGE) is oncogenic and overexpressed in human cancers, but its role in hepatocellular carcinoma remains unclear. Here we demonstrated that RAGE is overexpressed in primary hepatocellular carcinoma (PHC) compared to adjacent para-neoplastic liver samples. Serum endogenous secretory RAGE levels were also increased in PHC patients (p < 0.01). Moreover, we demonstrated that RAGE regulates cellular proliferation in Hepatocellular carcinoma (HCC). Knockdown of RAGE by specific siRNA inhibited cellular growth in the hepatocellular carcinoma cell line, Huh7, whereas the RAGE ligand, high mobility group box 1 protein (HMGB1) increased cellular proliferation. In addition, knockdown of RAGE by siRNA arrested cells in the G1 phase and inhibited DNA synthesis (p < 0.01), while HMGB1 protein decreased the number of cells in the G1 phase and increased the number in the S phase (p < 0.05). Furthermore, quantitative real time RT-PCR (qRT-PCR) and Western Blot results demonstrated that RAGE and HMGB1 positively regulate NF-κB p65 expression in Huh7 cells. These studies suggest that RAGE and RAGE ligands are important targets for therapeutic intervention in hepatocellular carcinoma.

KW - HMGB1

KW - NF-κb

KW - Proliferation

KW - RAGE

KW - SiRNA

UR - http://www.scopus.com/inward/record.url?scp=84861540170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861540170&partnerID=8YFLogxK

U2 - 10.3390/ijms13055982

DO - 10.3390/ijms13055982

M3 - Article

C2 - 22754344

AN - SCOPUS:84861540170

VL - 13

SP - 5982

EP - 5997

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 5

ER -